Director/PDMR Shareholding

RNS Number : 1926L

GlaxoSmithKline PLC

20 December 2018

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr R Simard
b)	Position/status	President, Pharma Supply Chain
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Cash payout of £47,832.11 less applicable tax withholding in respect of 3,231.899 notional Ordinary Shares following vesting of an award made on 16 December 2013 under the GlaxoSmithKline Deferred Investment Award plan.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£14.8000	3231.899
d)	Aggregated information	n/a (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2018-12-17
f)	Place of the transaction	n/a

 

END

 

 

DSHDBLFLVLFFFBZ